'Chair nf clinical consortium' presentation slideshows

A Phase 2 Study of The mTOR Inhibitor Sirolimus in NF1 Related Plexiform Neurofibromas

Sirolimus for NF1 Associated Plexiform Neurofibromas. A Phase 2 Study of The mTOR Inhibitor Sirolimus in NF1 Related Plexiform Neurofibromas. Brian Weiss, MD, Chair Michael Fisher, MD, Co - Chair Bruce Korf , MD, PhD, Co-Chair John Perentesis , MD, Co- Chair

382 views • 21 slides